ID FER1_AZOVI Reviewed; 107 AA. AC P00214; DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 2. DT 27-MAR-2024, entry version 137. DE RecName: Full=Ferredoxin-1; DE AltName: Full=Ferredoxin I; DE Short=FdI; GN Name=fdxA; OS Azotobacter vinelandii. OC Bacteria; Pseudomonadota; Gammaproteobacteria; Pseudomonadales; OC Pseudomonadaceae; Azotobacter. OX NCBI_TaxID=354; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=2826477; DOI=10.1016/s0021-9258(19)57312-4; RA Morgan T.V., Lundell D.J., Burgess B.K.; RT "Azotobacter vinelandii ferredoxin I: cloning, sequencing, and mutant RT analysis."; RL J. Biol. Chem. 263:1370-1375(1988). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=ATCC 13705 / OP1 / DSM 366 / NCIMB 11614 / LMG 3878 / UW; RX PubMed=8244942; DOI=10.1128/jb.175.23.7707-7710.1993; RA Le O., Shen B., Iismaa S.E., Burgess B.K.; RT "Azotobacter vinelandii mutS: nucleotide sequence and mutant analysis."; RL J. Bacteriol. 175:7707-7710(1993). RN [3] RP PROTEIN SEQUENCE OF 2-107, AND X-RAY CRYSTALLOGRAPHY (2 ANGSTROMS). RX PubMed=6848518; DOI=10.1016/s0021-9258(18)33285-x; RA Howard J.B., Lorsbach T.W., Ghosh D., Melis K., Stout C.D.; RT "Structure of Azotobacter vinelandii 7Fe ferredoxin. Amino acid sequence RT and electron density maps of residues."; RL J. Biol. Chem. 258:508-522(1983). RN [4] RP X-RAY CRYSTALLOGRAPHY (2 ANGSTROMS). RX PubMed=7120409; DOI=10.1016/0022-2836(82)90451-x; RA Ghosh D., O'Donnell S., Furey W.F. Jr., Robbins A.H., Stout C.D.; RT "Iron-sulfur clusters and protein structure of Azotobacter ferredoxin at RT 2.0-A resolution."; RL J. Mol. Biol. 158:73-109(1982). RN [5] RP X-RAY CRYSTALLOGRAPHY (3 ANGSTROMS). RX PubMed=3422475; DOI=10.1073/pnas.85.4.1020; RA Stout G.H., Turley S., Sieker L.C., Jensen L.H.; RT "Structure of ferredoxin I from Azotobacter vinelandii."; RL Proc. Natl. Acad. Sci. U.S.A. 85:1020-1022(1988). RN [6] RP X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS). RX PubMed=2926817; DOI=10.1016/0022-2836(89)90225-8; RA Stout G.H.; RT "Refinement of the 7 Fe ferredoxin from Azotobacter vinelandii at 1.9-A RT resolution."; RL J. Mol. Biol. 205:545-555(1989). RN [7] RP X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS). RX PubMed=15299532; DOI=10.1107/s0907444992007248; RA Merritt E.A., Stout G.H., Turley S., Sieker L.C., Jensen L.H., RA Orme-Johnson W.H.; RT "Structure at pH 6.5 of ferredoxin I from Azotobacter vinelandii at 2.3-A RT resolution."; RL Acta Crystallogr. D 49:272-281(1993). RN [8] RP X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS). RX PubMed=9600844; DOI=10.1006/jmbi.1998.1732; RA Stout C.D., Stura E.A., McRee D.E.; RT "Structure of Azotobacter vinelandii 7Fe ferredoxin at 1.35-A resolution RT and determination of the [Fe-S] bonds with 0.01-A accuracy."; RL J. Mol. Biol. 278:629-639(1998). RN [9] RP X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS). RX PubMed=10387068; DOI=10.1021/bi983008i; RA Schipke C.G., Goodin D.B., McRee D.E., Stout C.D.; RT "Oxidized and reduced Azotobacter vinelandii ferredoxin I at 1.4-A RT resolution: conformational change of surface residues without significant RT change in the [3Fe-4S]+/0 cluster."; RL Biochemistry 38:8228-8239(1999). RN [10] RP X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS). RX PubMed=10593945; DOI=10.1074/jbc.274.51.36479; RA Chen K., Tilley G.J., Sridhar V., Prasad G.S., Stout C.D., Armstrong F.A., RA Burgess B.K.; RT "Alteration of the reduction potential of the [4Fe-4S](2+/+) cluster of RT Azotobacter vinelandii ferredoxin I."; RL J. Biol. Chem. 274:36479-36487(1999). RN [11] RP DNA-BINDING. RX PubMed=1855590; DOI=10.1016/0014-5793(91)80807-f; RA Thomson A.J.; RT "Does ferredoxin I (Azotobacter) represent a novel class of DNA-binding RT proteins that regulate gene expression in response to cellular iron(II)?"; RL FEBS Lett. 285:230-236(1991). RN [12] RP MUTAGENESIS. RX PubMed=2153958; DOI=10.1073/pnas.87.2.598; RA Martin A.E., Burgess B.K., Stout C.D., Cash V.L., Dean D.R., Jensen G.M., RA Stephens P.J.; RT "Site-directed mutagenesis of Azotobacter vinelandii ferredoxin I: [Fe-S] RT cluster-driven protein rearrangement."; RL Proc. Natl. Acad. Sci. U.S.A. 87:598-602(1990). RN [13] RP MUTAGENESIS. RX PubMed=1657971; DOI=10.1016/s0021-9258(18)54675-5; RA Iismaa S.E., Vazquez A.E., Jensen G.M., Stephens P.J., Butt J.N., RA Armstrong F.A., Burgess B.K.; RT "Site-directed mutagenesis of Azotobacter vinelandii ferredoxin I. Changes RT in [4Fe-4S] cluster reduction potential and reactivity."; RL J. Biol. Chem. 266:21563-21571(1991). RN [14] RP MUTAGENESIS. RX PubMed=8132582; DOI=10.1016/s0021-9258(17)37232-0; RA Shen B., Jollie D.R., Stout C.D., Diller T.C., Armstrong F.A., Gorst C.M., RA la Mar G.N., Stephen P.J., Burgess B.K.; RT "Azotobacter vinelandii ferredoxin I. Alteration of individual surface RT charges and the [4FE-4S]2+/+ cluster reduction potential."; RL J. Biol. Chem. 269:8564-8575(1994). CC -!- FUNCTION: Ferredoxins are iron-sulfur proteins that transfer electrons CC in a wide variety of metabolic reactions. This ferredoxin could play a CC role in regulating gene expression by interacting directly with DNA. CC -!- COFACTOR: CC Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883; CC Note=Binds 1 [4Fe-4S] cluster.; CC -!- COFACTOR: CC Name=[3Fe-4S] cluster; Xref=ChEBI:CHEBI:21137; CC Note=Binds 1 [3Fe-4S] cluster.; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Redox potential: CC E(0) is -450 mV for the 3Fe-4S, and -645 mV for the 4Fe-4S clusters.; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; J03521; AAA22125.1; -; Genomic_DNA. DR EMBL; M63007; AAA16869.1; -; Unassigned_DNA. DR PIR; A29936; FEAV. DR RefSeq; WP_012702380.1; NZ_FPKM01000003.1. DR PDB; 1A6L; X-ray; 2.10 A; A=2-107. DR PDB; 1AXQ; X-ray; 2.10 A; A=2-107. DR PDB; 1B0T; X-ray; 2.10 A; A=2-107. DR PDB; 1B0V; X-ray; 2.80 A; A/B/C/D=2-107. DR PDB; 1D3W; X-ray; 1.70 A; A=2-107. DR PDB; 1F5B; X-ray; 1.62 A; A=2-107. DR PDB; 1F5C; X-ray; 1.75 A; A=2-107. DR PDB; 1FD2; X-ray; 1.90 A; A=2-107. DR PDB; 1FDA; X-ray; 2.10 A; A=2-107. DR PDB; 1FDB; X-ray; 2.20 A; A=2-107. DR PDB; 1FDD; X-ray; 1.90 A; A=2-107. DR PDB; 1FER; X-ray; 2.30 A; A=2-107. DR PDB; 1FF2; X-ray; 2.30 A; A=2-107. DR PDB; 1FRH; X-ray; 2.30 A; A=2-107. DR PDB; 1FRI; X-ray; 2.10 A; A=2-107. DR PDB; 1FRJ; X-ray; 2.30 A; A=2-107. DR PDB; 1FRK; X-ray; 2.10 A; A=2-107. DR PDB; 1FRL; X-ray; 2.30 A; A=2-107. DR PDB; 1FRM; X-ray; 2.30 A; A=2-107. DR PDB; 1FRX; X-ray; 2.50 A; A=2-107. DR PDB; 1FTC; X-ray; 2.35 A; A/B=2-107. DR PDB; 1G3O; X-ray; 1.65 A; A=2-107. DR PDB; 1G6B; X-ray; 1.90 A; A=2-107. DR PDB; 1GAO; X-ray; 2.20 A; A/B/C/D=2-107. DR PDB; 1PC4; X-ray; 1.65 A; A=1-107. DR PDB; 1PC5; X-ray; 1.80 A; A=1-107. DR PDB; 2FD2; X-ray; 1.90 A; A=2-107. DR PDB; 5FD1; X-ray; 1.90 A; A=2-107. DR PDB; 6FD1; X-ray; 1.35 A; A=2-107. DR PDB; 6FDR; X-ray; 1.40 A; A=2-107. DR PDB; 7FD1; X-ray; 1.30 A; A=2-107. DR PDB; 7FDR; X-ray; 1.40 A; A=2-107. DR PDBsum; 1A6L; -. DR PDBsum; 1AXQ; -. DR PDBsum; 1B0T; -. DR PDBsum; 1B0V; -. DR PDBsum; 1D3W; -. DR PDBsum; 1F5B; -. DR PDBsum; 1F5C; -. DR PDBsum; 1FD2; -. DR PDBsum; 1FDA; -. DR PDBsum; 1FDB; -. DR PDBsum; 1FDD; -. DR PDBsum; 1FER; -. DR PDBsum; 1FF2; -. DR PDBsum; 1FRH; -. DR PDBsum; 1FRI; -. DR PDBsum; 1FRJ; -. DR PDBsum; 1FRK; -. DR PDBsum; 1FRL; -. DR PDBsum; 1FRM; -. DR PDBsum; 1FRX; -. DR PDBsum; 1FTC; -. DR PDBsum; 1G3O; -. DR PDBsum; 1G6B; -. DR PDBsum; 1GAO; -. DR PDBsum; 1PC4; -. DR PDBsum; 1PC5; -. DR PDBsum; 2FD2; -. DR PDBsum; 5FD1; -. DR PDBsum; 6FD1; -. DR PDBsum; 6FDR; -. DR PDBsum; 7FD1; -. DR PDBsum; 7FDR; -. DR AlphaFoldDB; P00214; -. DR SMR; P00214; -. DR OMA; DRMLYIH; -. DR EvolutionaryTrace; P00214; -. DR GO; GO:0051538; F:3 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW. DR GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW. DR GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW. DR GO; GO:0009055; F:electron transfer activity; IEA:InterPro. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR Gene3D; 3.30.70.20; -; 1. DR InterPro; IPR017896; 4Fe4S_Fe-S-bd. DR InterPro; IPR017900; 4Fe4S_Fe_S_CS. DR InterPro; IPR000813; 7Fe_ferredoxin. DR InterPro; IPR022569; Fd_C. DR PANTHER; PTHR42859:SF2; FERREDOXIN; 1. DR PANTHER; PTHR42859; OXIDOREDUCTASE; 1. DR Pfam; PF11953; DUF3470; 1. DR Pfam; PF00037; Fer4; 1. DR PRINTS; PR00354; 7FE8SFRDOXIN. DR SUPFAM; SSF54862; 4Fe-4S ferredoxins; 1. DR PROSITE; PS00198; 4FE4S_FER_1; 1. DR PROSITE; PS51379; 4FE4S_FER_2; 2. PE 1: Evidence at protein level; KW 3D-structure; 3Fe-4S; 4Fe-4S; Direct protein sequencing; DNA-binding; KW Electron transport; Iron; Iron-sulfur; Metal-binding; Repeat; Transport. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|PubMed:6848518" FT CHAIN 2..107 FT /note="Ferredoxin-1" FT /id="PRO_0000159095" FT DOMAIN 2..30 FT /note="4Fe-4S ferredoxin-type 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00711" FT DOMAIN 31..60 FT /note="4Fe-4S ferredoxin-type 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00711" FT REGION 84..107 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 9 FT /ligand="[3Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:21137" FT /evidence="ECO:0000269|PubMed:3422475" FT BINDING 17 FT /ligand="[3Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:21137" FT /evidence="ECO:0000269|PubMed:3422475" FT BINDING 21 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /evidence="ECO:0000269|PubMed:3422475" FT BINDING 40 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /evidence="ECO:0000269|PubMed:3422475" FT BINDING 43 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /evidence="ECO:0000269|PubMed:3422475" FT BINDING 46 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /evidence="ECO:0000269|PubMed:3422475" FT BINDING 50 FT /ligand="[3Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:21137" FT /evidence="ECO:0000269|PubMed:3422475" FT CONFLICT 49 FT /note="E -> R (in Ref. 2; AAA16869)" FT /evidence="ECO:0000305" FT CONFLICT 53 FT /note="Q -> E (in Ref. 3; AA sequence)" FT /evidence="ECO:0000305" FT STRAND 3..5 FT /evidence="ECO:0007829|PDB:7FD1" FT HELIX 7..9 FT /evidence="ECO:0007829|PDB:7FD1" FT TURN 10..12 FT /evidence="ECO:0007829|PDB:7FD1" FT HELIX 16..20 FT /evidence="ECO:0007829|PDB:7FD1" FT STRAND 22..24 FT /evidence="ECO:0007829|PDB:1FD2" FT STRAND 26..28 FT /evidence="ECO:0007829|PDB:7FD1" FT STRAND 33..35 FT /evidence="ECO:0007829|PDB:7FD1" FT TURN 37..39 FT /evidence="ECO:0007829|PDB:7FD1" FT HELIX 47..49 FT /evidence="ECO:0007829|PDB:7FD1" FT STRAND 55..57 FT /evidence="ECO:0007829|PDB:7FD1" FT HELIX 58..60 FT /evidence="ECO:0007829|PDB:7FD1" FT HELIX 63..66 FT /evidence="ECO:0007829|PDB:7FD1" FT HELIX 67..75 FT /evidence="ECO:0007829|PDB:7FD1" FT TURN 76..78 FT /evidence="ECO:0007829|PDB:7FD1" FT HELIX 92..95 FT /evidence="ECO:0007829|PDB:7FD1" FT HELIX 101..104 FT /evidence="ECO:0007829|PDB:7FD1" SQ SEQUENCE 107 AA; 12182 MW; 3B4B0D1A55765B2B CRC64; MAFVVTDNCI KCKYTDCVEV CPVDCFYEGP NFLVIHPDEC IDCALCEPEC PAQAIFSEDE VPEDMQEFIQ LNAELAEVWP NITEKKDPLP DAEDWDGVKG KLQHLER //